Most clinical protocols recommend starting THC for pain at just 1 to 2.5 mg per day and increasing gradually, which is far lower than many people expect. The “right” dose varies dramatically from person to person, and research consistently shows that more THC does not necessarily mean more pain relief. Getting the dose wrong in either direction carries real consequences: too little and you get no benefit, too much and the side effects can outweigh the relief.
The Clinical Dosing Protocols
The most widely referenced dosing framework for medical cannabis in chronic pain comes from a consensus guideline that lays out three tracks depending on the patient’s situation. The standard protocol starts not with THC at all, but with CBD alone at 5 mg twice a day, increasing by 10 mg every two to three days up to 40 mg per day. Only if CBD alone fails do you add THC, beginning at 2.5 mg per day and increasing by 2.5 mg every two to seven days. The ceiling is 40 mg per day of THC, though many people find relief well below that.
A conservative protocol exists for people who are sensitive to drug effects. It follows the same CBD-first approach but adds THC even more slowly, starting at just 1 mg per day and increasing by 1 mg per week. A rapid protocol is reserved for people with severe pain who need faster relief or who already have cannabis experience. It starts with a balanced THC-to-CBD product at 2.5 to 5 mg of each, taken once or twice daily, and increases by 2.5 to 5 mg every few days.
1PubMed Central. Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic PainThe key principle across all three tracks is “start low, go slow.” The goal is to find the minimum effective dose, not to push THC as high as possible. Pain relief tends to plateau at a certain point, and side effects like dizziness, sedation, and anxiety climb steeply if you overshoot.
Inhaled THC Works Differently Than Oral THC
How you take THC changes both the dose you need and how quickly it hits. Inhaled THC, whether vaporized or smoked, reaches peak blood levels within minutes. The effect typically lasts two to three hours. Oral THC, including edibles and oils, can take 30 minutes to two hours to kick in and may last six hours or longer. This slow onset is exactly why edibles are easy to overdose on: people take more because they don’t feel anything yet, and then both doses arrive at once.
For inhaled cannabis, the doses studied in clinical pain trials are surprisingly small. A trial of 39 patients with neuropathic pain tested vaporized cannabis at two strengths, 1.29% and 3.53% THC. Both doses produced meaningful pain relief, and there was no significant difference between the two. The number of patients you would need to treat with the low dose to get one person a 30% pain reduction was about 3, essentially the same as the medium dose.
2PubMed Central. Low-dose vaporized cannabis significantly improves neuropathic painThat finding is worth sitting with. The low-dose and medium-dose groups got roughly the same relief. This is one of the clearest pieces of evidence that cranking up the THC content of what you inhale may not buy you additional benefit for pain, while it does buy you more impairment, anxiety, and other unwanted effects.
A separate crossover study of patients with neuropathic pain found similar results with metered vaporized doses. Inhaling about 10 mg of THC spread over two sessions reduced pain intensity by roughly 30% at three hours and 25% at five hours. Increasing the dose to about 28 mg produced essentially the same level of pain reduction, not more.
3PubMed Central. Safety of Medical Cannabis in Neuropathic Chronic Pain ManagementFor oral dosing used in the clinical protocols, the typical starting range of 1 to 5 mg of THC reflects the fact that swallowed THC undergoes extensive first-pass metabolism in the liver, which converts it into a metabolite that is itself psychoactive. This means oral THC can produce stronger and longer-lasting effects than inhaled THC milligram for milligram, even though it takes longer to feel.
Why the Same Dose Hits People Differently
One of the most frustrating aspects of THC dosing is the enormous person-to-person variability. Two people can take the same 5 mg edible and have wildly different experiences, from barely noticeable to overwhelmingly intoxicated. Several factors drive this spread.
Liver enzymes play a major role. A family of enzymes called CYP2C9 handles roughly 70% of THC metabolism, converting it into its active metabolite.
4PubMed Central. CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1) People carry different genetic variants of this enzyme. Some are fast metabolizers who chew through THC quickly and may need higher doses for the same effect. Others are slow metabolizers who build up higher blood levels from the same dose, making them more sensitive to effects and side effects. You can’t know your metabolizer status without genetic testing, but if you’ve always found that cannabis hits you harder than your friends at the same dose, slow metabolism is one likely explanation.
Biological sex also appears to matter, at least in animal research. In a rat study, THC was significantly more potent in females than in males at producing pain relief on two different pain tests.
5PubMed Central. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat Human data on sex differences in cannabis pain relief are still limited, but this finding tracks with clinical observations that women sometimes report stronger effects at lower doses.
Age matters too. Older adults face a specific set of risks: they’re more likely to be on multiple medications that could interact with THC, their liver and kidney function may process the drug more slowly, and they are more vulnerable to cardiovascular side effects and falls from dizziness. Clinical guidance recommends extra caution, careful risk-benefit analysis, and frequent monitoring when using medical cannabis in older patients.
6PubMed Central. Medical Cannabis for Older Patients-Treatment Protocol and Initial ResultsBody composition, prior cannabis experience, the specific pain condition, and even your mood and stress level on a given day can all shift how THC affects you. This is why clinical dosing protocols build in slow titration rather than prescribing a fixed number. You’re searching for your own effective dose, not hitting a universal target.
How THC Actually Reduces Pain
THC doesn’t work like a standard painkiller. It activates cannabinoid receptors in the brain and spinal cord, which adjust how strongly your nervous system registers pain signals. These receptors, when activated, raise the threshold for what your body considers painful, tamp down the release of inflammatory molecules, and interact with the body’s own opioid system in ways that amplify pain relief.
7PubMed Central. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodesThis last point, the interaction with the opioid system, is clinically significant. A meta-analysis of preclinical studies found that when THC was given alongside morphine, the effective dose of morphine dropped by about 3.6 times. With codeine, the effective dose dropped by roughly 9.5 times.
8PubMed Central. Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis These are animal data, so translating them directly to human doses isn’t straightforward, but the direction of the finding is clear. Adding THC may allow lower opioid doses, which matters enormously for people managing chronic pain with opioid prescriptions where side effects and dependence risk scale with dose.
There’s also a theory that some chronic pain conditions, including migraine, fibromyalgia, and irritable bowel syndrome, involve a natural deficit in the body’s own cannabinoid signaling. The idea is that these conditions share overlapping symptoms of heightened pain sensitivity and that boosting cannabinoid activity from the outside could compensate for what the body isn’t producing on its own.
9PubMed Central. Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes This remains a hypothesis rather than proven science, but it helps explain why some patients with these conditions report benefit from cannabis at lower doses than you’d expect.
What CBD Adds to the Mix
You’ll notice that the clinical dosing protocols described earlier start with CBD before adding THC. This isn’t arbitrary. CBD has its own mild anti-inflammatory and pain-modifying effects, and it can change how your body handles THC in important ways. In animal research, CBD inhibited THC metabolism when given by oral or injection routes, resulting in higher THC levels in both blood and brain.
10PubMed Central. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC In practical terms, this means that taking CBD alongside THC can amplify and extend the THC effect, which is why balanced products containing both cannabinoids often feel stronger per milligram of THC than THC-only products.
CBD is also widely believed to soften some of the less pleasant effects of THC, like anxiety and paranoia, though the evidence for this in controlled human trials is less airtight than the popular narrative suggests. Still, starting with CBD and adding THC incrementally serves a dual purpose: it allows the CBD to build up in your system and establish whatever baseline anti-inflammatory effect it offers, while giving you a buffer against THC side effects when you begin adding it.
Tolerance Changes Everything Over Time
If you use THC regularly for pain, your dose will not stay the same forever. Tolerance develops as the brain’s cannabinoid receptors are gradually downregulated and become less responsive to stimulation.
11PubMed Central. Mechanisms of Cannabinoid Tolerance In chronic daily cannabis users, brain imaging has shown roughly 20% lower receptor availability in certain brain regions compared to non-users.
12PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokersA large real-world dataset put a number on the tolerance effect: people experienced about a 0.5% decrease in symptom relief with each successive use session. To counterbalance the tolerance from just one additional session, you would theoretically need to increase your product’s THC concentration by 4.4 percentage points, an escalation that quickly becomes impractical.
13PubMed Central. Cannabis tolerance reduces symptom relief What people actually did in that dataset was increase the amount consumed per session rather than switch to stronger products, which amounts to the same thing: more THC over time for the same relief.
The encouraging news is that this downregulation appears to be reversible. In the imaging study mentioned above, after roughly four weeks of monitored abstinence, receptor levels in the affected brain regions bounced back.
12PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers This is the rationale behind “tolerance breaks,” where people stop using cannabis for a period to reset their sensitivity. For chronic pain patients, taking a complete break may not be feasible, but some clinicians recommend periodic dose reductions or rotating between THC-dominant and CBD-dominant products to slow tolerance buildup.
Terpenes and the Entourage Effect
THC doesn’t work in isolation inside a whole-plant cannabis product. The plant contains dozens of aromatic compounds called terpenes, and there’s growing interest in whether these contribute to pain relief independently or amplify what THC does. This idea, sometimes called the entourage effect, proposes that the whole plant is more effective than THC alone.
14PubMed Central. Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain SyndromesSome animal data support this. In a mouse model of chemotherapy-induced nerve pain, terpenes from cannabis produced measurable pain relief on their own. When combined with a low dose of morphine, all tested terpenes produced significantly greater relief than either treatment alone.
15PubMed Central. Terpenes from Cannabis sativa Induce Antinociception in a Mouse Model of Chronic Neuropathic Pain via Activation of Adenosine A2A Receptors The mechanism appeared to involve adenosine receptors, which are a separate pain-signaling pathway from the one THC acts on.
What this means for dosing is still speculative, but it suggests that choosing a whole-plant product rather than pure THC isolate could offer more pain relief at a given THC dose. Dispensaries now routinely list terpene profiles on product labels, and while the science is still early, paying attention to these profiles rather than shopping purely by THC percentage may be a smarter strategy.
Pain Conditions Where Evidence Is Thin
Most of the well-controlled THC dosing data comes from neuropathic pain, the kind of pain caused by nerve damage or dysfunction. For other common chronic pain conditions, the picture is murkier. Rheumatoid diseases like rheumatoid arthritis, osteoarthritis, and fibromyalgia are characterized by progressive inflammation in the joints and surrounding tissue. Preclinical studies on cannabinoids in these conditions have shown promising results for both reducing inflammation and relieving pain, but clinical studies in actual patients are scarce and the results so far are mixed. No established dosing recommendations exist specifically for these conditions.
16PubMed Central. Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research DirectionsThis gap matters for patients. If you’re trying THC for joint pain or fibromyalgia, you’re largely borrowing dosing wisdom from neuropathic pain studies and working through trial and error. The general “start low, go slow” principle still applies, but you should have realistic expectations. The pain relief that has been most convincingly demonstrated in controlled trials is for nerve-related pain specifically. For inflammatory and musculoskeletal pain, THC may still help, but the evidence base supporting any specific dose is much weaker.
Practical Mistakes People Make With THC Dosing
The most common dosing error is impatience. Someone tries 2.5 mg of an edible, feels nothing after an hour, takes another 5 mg, and ends up profoundly uncomfortable when both doses hit simultaneously. Oral THC can take up to two hours to reach full effect, sometimes longer if you’ve eaten a heavy meal. The clinical protocols recommend waiting two to seven days between dose increases for exactly this reason: you need time at each level to judge whether it’s working before you escalate.
Another frequent mistake is chasing the high rather than the relief. Pain relief from THC often occurs at doses below or at the threshold of noticeable intoxication. If you’re getting noticeably impaired, you may have already passed the sweet spot. The neuropathic pain trials consistently show that lower THC doses match or come close to higher doses in analgesic effect, while the higher doses add more side effects.
People also underestimate how much variability exists between products, even products that are labeled identically. Cannabis regulation varies widely by jurisdiction, and lab testing accuracy is not uniform. A gummy labeled 10 mg might contain 7 or 13. This is another argument for starting conservatively: if your first product happens to be one that runs hot, a cautious starting dose protects you.
Finally, some people abandon cannabis for pain too quickly because their first product or dose didn’t work. Given the number of variables involved, including the route, the THC-to-CBD ratio, the specific product, the terpene profile, and individual metabolism, one failed attempt doesn’t mean cannabis won’t work for you. It means that particular combination at that dose didn’t work, and adjusting any one of those variables might change the outcome.